Archives: Search / 2013 / 2012 / 2011

2012 Archives

Dec 14, 2012

Sequenom Provides Update On Status Of Patent For Methods Of Detecting Fetal Aneuploidy

Dec 11, 2012

Sequenom Announces Leadership Appointments

Dec 6, 2012

Sequenom, Inc. Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy

Dec 6, 2012

Sequenom Announces Participation at Oppenheimer 23rd Annual Healthcare Conference

Nov 21, 2012

The American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee Recommend Noninvasive Prenatal Testing for Fetal Aneuploidy

Nov 12, 2012

Study Shows Sequenom CMM's RetnaGene LDT Accurately Predicts Risk of Progression to Wet Form of AMD

Results Evaluating Genetic Test Presented at AAO Annual Meeting

Nov 8, 2012

Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2012 And Announces 90,000 Annualized Run Rate For MaterniT21™ PLUS Tests

Forty-Six Million Lives Now Under Coverage For Sequenom CMM MaterniT21™ PLUS Test

Nov 6, 2012

Sequenom Announces Participation At Two Upcoming Investor Conferences

Oct 18, 2012

California Technology Assessment Forum Recommends Use Of Cell-Free DNA Technology As Advanced Prenatal Testing For Pregnant Women At High Risk For Fetal Chromosomal Anomalies

Oct 15, 2012

Sequenom, Inc. Announces Date Of Third Quarter 2012 Financial Results And Conference Call

Oct 11, 2012

Sequenom Announces Appointment Of Bill Bowen To Senior Vice President And General Counsel

Sep 17, 2012

Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Offering Of $130 Million Of 5.00% Convertible Senior Notes

Sep 12, 2012

Sequenom Prices Offering of $110 Million of its 5.00% Convertible Senior Notes Due 2017

Sep 12, 2012

Sequenom Announces Participation At Two Upcoming Investor Conferences

Sep 10, 2012

Sequenom Announces Proposed Offering Of $100 Million Of Convertible Senior Notes

Sep 5, 2012

Sequenom Announces Participation At The Morgan Stanley Global Healthcare Conference

Sep 4, 2012

Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors

Aug 28, 2012

Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service

Nearly 27,000 Total MaterniT21 PLUS LDT U.S. Samples Accessioned, Increased Annual Run Rate

Aug 20, 2012

LifeCodexx Launches PraenaTest® in Germany, Austria, Liechtenstein and Switzerland With Sequenom-Licensed Technology

Aug 8, 2012

Sequenom Announces Participation At The Wedbush PacGrow Lifesciences Management Access Conference

Jul 26, 2012

Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2012 And Increases Full-Year MaterniT21™ PLUS Test Volume Goal To 50,000

Company Announces More Than 20,000 Sequenom CMM MaterniT21™ PLUS Tests Accessioned Since Launch

Jul 16, 2012

Sequenom, Inc. Files Notice Of Appeal Of Preliminary Injunction Denial

Jul 12, 2012

Sequenom, Inc. Announces Date Of Second Quarter 2012 Financial Results And Conference Call

Jul 6, 2012

Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent

Jun 27, 2012

Sequenom Announces Appointment of Carolyn Beaver to Chief Accounting Officer

1-25 26-47

RSS